CAMBRIDGE TRUST CO - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 123 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAMBRIDGE TRUST CO ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$10,150
-11.7%
5,0000.0%0.00%
-100.0%
Q2 2023$11,500
-24.1%
5,0000.0%0.00%0.0%
Q1 2023$15,150
+126150.0%
5,0000.0%0.00%0.0%
Q4 2022$12
-99.9%
5,0000.0%0.00%
Q3 2022$10,000
-28.6%
5,0000.0%0.00%
-100.0%
Q2 2022$14,000
-6.7%
5,0000.0%0.00%0.0%
Q1 2022$15,000
-21.1%
5,0000.0%0.00%0.0%
Q4 2021$19,0005,0000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2022
NameSharesValueWeighting ↓
COWEN AND COMPANY, LLC 4,331,020$7,882,0001.31%
RTW INVESTMENTS, LP 6,869,281$12,502,0000.35%
A.R.T. Advisors, LLC 14,140$26,0000.04%
Hudson Bay Capital Management LP 975,000$1,774,0000.03%
Secure Asset Management, LLC 10,000$18,0000.01%
OSAIC HOLDINGS, INC. 1,774,935$3,230,0000.01%
FNY Investment Advisers, LLC 9,900$18,0000.01%
Squarepoint Ops LLC 322,225$586,0000.01%
LMR Partners LLP 107,912$196,0000.01%
Virtu Financial LLC 17,147$31,0000.00%
View complete list of ARBUTUS BIOPHARMA CORP shareholders